The meeting will cover exciting new findings in the cell and gene therapy of diseases affecting all major organs and systems, cancer gene and cell therapy, cell reprogramming and stem cell biology, vector targeting and new technologies for gene editing and sitespecific integration, immune response to vector and cell transplantation. Most importantly, the most recent clinical results in the treatment of several monogenic and acquired diseases will be presented, in some cases for the first time.
For more information: www.esgct.eu/congress/2010
